#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Amy Pooler Email
VP, Neuroscience . Sangamo Therapeutics
How to contact Amy Pooler
Join and see Amy's contact info for free!Current Roles
Employees:
436Revenue:
$108.5MAbout
Sangamo BioSciences (Nasdaq: SGMO) develops and markets novel transcription factors capable of regulating genes. The company’s powerful Universal Gene Recognition™ technology enables the engineering of a particular class of transcription factors known as zinc finger DNA-binding proteins, or ZFPs. By engineering ZFPs so that they can recognize a specific gene, Sangamo has created ZFP transcription factors that can control gene expression, and consequently, cell functionSangamo Therapeutics Address
7000 Marina BoulevardBrisbane, CA
United States